D-dimer, disease severity, and deaths (3D-study) in patients with COVID-19: a systematic review and meta-analysis of 100 studies
Abstract Hypercoagulability and the need for prioritizing coagulation markers for prognostic abilities have been highlighted in COVID-19. We aimed to quantify the associations of D-dimer with disease progression in patients with COVID-19. This systematic review and meta-analysis was registered with...
Guardado en:
Autores principales: | Seshadri Reddy Varikasuvu, Saurabh Varshney, Naveen Dutt, Manne Munikumar, Shahir Asfahan, Paresh P. Kulkarni, Pratima Gupta |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6cb0b55737d04873a08f2e3d98d5c1e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
D-dimer rise in outpatients with COVID 19 and comorbidities
por: Miljković Ana R.
Publicado: (2021) -
D-Dimer Tests in the Emergency Department: Current Insights
por: Innocenti F, et al.
Publicado: (2021) -
D-dimer, COVID-19 and Diabetes: A Correspondence
por: Sora Yasri PhD, et al.
Publicado: (2021) -
Correlation of D-Dimer level with outcome in traumatic brain injury
por: Pradip Prasad Subedi, et al.
Publicado: (2016) -
Elderly Population with COVID-19 and the Accuracy of Clinical Scales and D-Dimer for Pulmonary Embolism: The OCTA-COVID Study
por: Maribel Quezada-Feijoo, et al.
Publicado: (2021)